Form 4: Sotera Health Director and 10% Owner Granted Restricted Stock Units

Sotera Health Co. Director and 10% owner, Ruoxi Chen, was granted 19,132 restricted stock units (RSUs) on May 22, 2025, as part of the company's incentive plan.

Summary

• Ruoxi Chen, a Director and 10% owner of Sotera Health Co. (SHC), was granted 19,132 restricted stock units (RSUs) on May 22, 2025.
• These RSUs were granted under the Sotera Health Company 2020 Omnibus Incentive Plan.
• Each RSU represents the right to receive one share of Common Stock, subject to vesting conditions.
• The RSUs will vest in full on the earlier of May 22, 2026 (first anniversary of grant date) or the date immediately prior to the Issuer's next regular annual shareholders meeting, contingent on continued service as a non-employee director.
• Following this transaction, Mr. Chen beneficially owns a total of 80,781 securities, comprising 19,132 RSUs and 61,649 shares of Common Stock.

Sentiment

Score: 6

Explanation: The grant of Restricted Stock Units to a director is a standard compensation practice that aligns the director's interests with shareholders. It is a routine transaction and does not indicate significant positive or negative news beyond standard corporate governance.

Positives

• The grant of Restricted Stock Units (RSUs) to a director aligns the director's interests with those of shareholders, as the value of the RSUs is tied to the company's stock performance.
• The grant is part of the Sotera Health Company 2020 Omnibus Incentive Plan, indicating a structured approach to executive and director compensation.

Negatives

• The issuance of new RSUs, upon vesting and conversion to common stock, will result in a minor dilution of existing shareholders' equity.

Future Outlook

This Form 4 filing does not provide any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This Form 4 filing reports a routine insider equity grant, which is a common practice across various industries for director compensation and alignment. It does not provide information for broader industry trend analysis or competitive positioning.

Comparison to Industry Standards

• The grant of Restricted Stock Units (RSUs) to non-employee directors is a standard compensation practice in many publicly traded companies, including those in the healthcare services and sterilization industry. The specific size of the grant (19,132 RSUs) would typically be evaluated against peer companies' director compensation packages, but this document does not provide sufficient data for such a detailed comparison.

Corporate Governance

Related Party Transactions

• The RSU grant to Ruoxi Chen, a Director and 10% owner, constitutes a related party transaction as it involves compensation to an insider.

Stakeholder Impact

• Shareholders: Minor potential for dilution upon RSU vesting, but improved alignment of director interests with shareholder value.

Next Steps

• The RSUs are subject to vesting conditions, which will occur on the earlier of May 22, 2026, or the date immediately prior to the Issuer's next regular annual shareholders meeting, provided the director continues service.

Key Dates

Keywords

Sotera Health, SHC, Form 4, Restricted Stock Units, RSU, Insider Transaction, Director Compensation, Equity Grant, Common Stock, Beneficial Ownership